“…Studies in M5 null and mutant mice Thomsen et al, 2005;Wang et al, 2004) support the idea that dysfunction of dopamine/DARPP-32 signaling activated by muscarinic receptors, especially by M5 receptors, may contributes to the pathophysiology of schizophrenia and drug addiction. In addition, dopamine/DARPP-32 signaling can be a molecular target that mediates neurotoxicity of organophosphate (Torres-Altoro et al, 2011).…”